Revexepride is a highly selective5-HT4 receptoragonist, and a potential inducer ofCYP3A4 enzyme, used for the treatment of gastroesophageal reflux disease.

The human CYP isoenzymes are involved in the metabolism of revexepride, which is mainly metabolized in vitro in humans by CYP3A4 (99.9%) with a minor contribution of CYP2D6 (0.1%). Revexepride exhibits direct inhibition of human CYP3A4 in vitro with IC₅₀values of 16-49 μM^[1].

425.95

Solid

C₂₁H₃₂ClN₃O₄

219984-49-3

Room temperature in continental US; may vary elsewhere.

DMSO : ≥ 100 mg/mL(234.77 mM)

*"≥" means soluble, but saturation unknown.

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80℃, 6 months; -20℃, 1 month。-80℃ 储存时，请在 6 个月内使用，-20℃ 储存时，请在 1 个月内使用。